
|Articles|February 1, 2004
Phakic IOL delivers good results in FDA trial for myopia
Anaheim, CA-An increasing number of IOLs are being developed to achieve improved vision in patients with extreme levels of myopia. One such lens is the Artisan/ Verisyse phakic IOL (Ophtec USA/Advanced Medical Optics), said R. Doyle Stulting, MD, PhD, who reported the results of the FDA clinical study here at the American Academy of Ophthalmology annual meeting.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: The evolution of eye care on display at AAO 2025
2
AAO 2025: Philip J. Ferrone, MD, highlights safety and efficacy findings of gildeuretinol in Stargardt disease
3
AAO 2025: Clinical outcomes of early vs delayed pegcetacoplan treatment in GA
4
Ocular pickleball injuries rise sharply with increasing game popularity
5